Merck & Co. stock heads into the open with ex-dividend date approaching

At the close of the last session, Merck & Co. stock held its recent range on the NYSE, with volume near typical levels and a modest move against its reference index. Today the focus is on Merck & Co. stock ahead of its confirmed ex-dividend date on September 15, 2026.

Merck & Co. stock last closed on the NYSE in recent sessions with a modest daily percent change, keeping the shares within their established 52-week range and near the middle of that band in USD terms. In that session the move in Merck & Co. lagged its primary US reference index, which posted a stronger percent gain on the same date.

September 11, 2026 in numbers

Merck & Co., Inc. (ISIN US58933Y1055, NYSE: MRK) closed its last completed NYSE session before today on September 11, 2026 at a level in USD that remained comfortably within its 52-week high and low range, with the closing price closer to the range midpoint than to either extreme per NYSE data. On that date the shares recorded a single-day percent move that was smaller than the corresponding percent change in a broad US equity benchmark, underscoring a relatively muted reaction compared with the wider market. Intraday trading saw Merck & Co. shares move between a day low and day high that framed the closing price, with the close sitting between these extremes as expected from the reported range and confirming that day low was less than or equal to the close and day high greater than or equal to the close. Trading volume in that September 11, 2026 session was within the typical range for the stock over recent weeks, neither unusually high nor unusually low in absolute terms.

There was no single company-specific announcement identified in the latest session as a clear driver of Merck & Co., Inc. price action, and the stock instead tracked a combination of broader market and sector influences while maintaining its established technical range. The overall pattern left Merck & Co. shares modestly underperforming the primary US index on September 11, 2026, even as both closed higher than their respective prior sessions.

Ex-dividend and data today

Today, attention around Merck & Co. centers on its upcoming ex-dividend date. As Moomoo reports, Merck & Co. is scheduled to go ex-dividend on September 15, 2026, with shareholders of record entitled to receive a cash dividend of 0.85 USD per share payable on October 7, 2026. This confirmed corporate action may influence positioning in Merck & Co. stock around today’s session as investors weigh dividend entitlement against near-term price moves. In the broader backdrop, the economic calendar from Investing.com highlights several data releases in the coming days that may affect overall risk sentiment and interest-rate expectations, factors that can indirectly shape trading conditions for large US pharmaceutical stocks such as Merck & Co. across the week.